HCA Healthcare (HCA)
(Delayed Data from NYSE)
$415.54 USD
+9.06 (2.23%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $415.66 +0.12 (0.03%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$415.54 USD
+9.06 (2.23%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $415.66 +0.12 (0.03%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
Zacks News
HCA Healthcare (HCA) Q3 Earnings Beat, Revenues Decline Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) third-quarter results reflect a slight dip in expenses but lower revenues resulting from the havoc wreaked by Hurricane Ian on its Florida facilities.
HCA Healthcare (HCA) Q3 Earnings Top Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of 1.03% and 0.52%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights HCA Healthcare, Acadia Healthcare, Universal Health Services and Tenet Healthcare
by Zacks Equity Research
HCA Healthcare, Acadia Healthcare, Universal Health Services and Tenet Healthcare have been highlighted in this Industry Outlook article.
HCA Healthcare Q3 Preview: Can Shares Remain Healthy?
by Derek Lewis
Over the past three months, HCA shares have climbed notably, up a double-digit 15% and handily beating the S&P 500's decline of roughly 7%.
4 Stocks Navigating Through Hospital Industry Headwinds
by Kaibalya Pravo Dey
Increasing expenses amid inflation is shrinking margins for the Zacks Medical-Hospital industry players. However, HCA Healthcare (HCA), Acadia Healthcare (ACHC), Universal Health (UHS) and Tenet Healthcare (THC) are poised to win big with recovering patient volumes.
Factors Setting the Tone for HCA Healthcare (HCA) Q3 Earnings
by Zacks Equity Research
HCA Healthcare's (HCA) third-quarter results are expected to reflect better emergency room visits and outpatient surgeries, partly offset by the continued incidence of labor costs.
Earnings Preview: Universal Health Services (UHS) Q3 Earnings Expected to Decline
by Zacks Equity Research
Universal Health Services (UHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stocks Stabilize As Q3 Earnings Loom
by Mayur Thaker
Market takes a breather from selling as all eyes turn towards corporate earnings to determine medium-term future.
Analysts Estimate HCA Healthcare (HCA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HCA Healthcare (HCA) Eyes 3 Hospital Divestments for $150M
by Zacks Equity Research
The divestment by HCA Healthcare (HCA) is likely to leave LCMC Health and Ochsner Health as the two major hospital care providers in the New Orleans region.
Here's Why You Should Buy McKesson (MCK) Stock Right Now
by Zacks Equity Research
McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
HCA Healthcare (HCA) Invests in VitalConnect's Remote Monitoring
by Zacks Equity Research
HCA Healthcare's (HCA) investment is likely to advance technology in the medical space, helping patients as well as professionals.
Why Is Universal Health Services (UHS) Down 5.3% Since Last Earnings Report?
by Zacks Equity Research
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Buy McKesson (MCK) Stock Right Now
by Zacks Equity Research
McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
Pediatrix (MD) Up 8% Since Q2 Earnings Release, Revenues Up Y/Y
by Zacks Equity Research
Pediatrix's (MD) second-quarter results reflect growth in patient volumes. Adjusted EBITDA is expected within $260-$270 million for 2022.
Universal Health (UHS) Q2 Earnings Beat on Strong Segments
by Zacks Equity Research
Universal Health's (UHS) second-quarter results benefit from strong contributions from Acute Care Hospital Services and Behavioral Health Care Services segments, partly offset by elevated operating costs.
Company News for Jul 25, 2022
by Zacks Equity Research
Companies In The News Are: VZ, AXP, HCA, NEE.
Beat the Market the Zacks Way: NetEase, HCA, Intuit, Illinois Tool Works in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our last week's achievements.
HCA Healthcare (HCA) Q2 Earnings Beat on Better Patient Volumes
by Zacks Equity Research
HCA Healthcare's (HCA) second-quarter results reflect improved revenues stemming from better same-facility emergency room visits. However, the results were partly offset by elevated salaries and benefits cost.
HCA Healthcare (HCA) Beats Q2 Earnings Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of 14.71% and 0.31%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for HCA Healthcare's (HCA) Q2 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) second-quarter results are likely to benefit from better patient volumes. The results might partly suffer from escalating labor costs that might dampen bottom line growth.
HCA Healthcare (HCA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, HCA Healthcare (HCA) closed at $171.69, marking a +0.05% move from the previous day.
Earnings Preview: Universal Health Services (UHS) Q2 Earnings Expected to Decline
by Zacks Equity Research
Universal Health Services (UHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate HCA Healthcare (HCA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HCA Healthcare (HCA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed at $169.39 in the latest trading session, marking a -1.86% move from the prior day.